Identification of and Structural Insights into Hit Compounds

Combination of In Silico and In Vitro Screening to Identify Novel Glutamate Carboxypeptidase II Inhibitors

Turning high-throughput structural biology into predictive inhibitor design

Hit-to-lead in drug discovery

Deep Docking: A Deep Learning Platform for Augmentation of Structure Based Drug Discovery

Frontiers In silico identification of potential inhibitors of acyl carrier protein reductase and acetyl CoA carboxylase of Plasmodium falciparum in antimalarial therapy

Full article: New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents

Identification of Novel CB2 Ligands through Virtual Screening and In Vitro Evaluation

Structural Insights into Pseudokinase Domains of Receptor Tyrosine Kinases - ScienceDirect

High-resolution structural information of membrane-bound α-synuclein provides insight into the MoA of the anti-Parkinson drug UCB0599

Structure-guided engineering of a receptor-agonist pair for inducible activation of the ABA adaptive response to drought

Screening strategies for identifying RNA- and ribonucleoprotein-targeted compounds: Trends in Pharmacological Sciences

Phenotypic screening with target identification and validation in the discovery and development of E3 ligase modulators - ScienceDirect

Artificial intelligence for drug discovery: Resources, methods, and applications: Molecular Therapy - Nucleic Acids